CORE
đŸ‡ºđŸ‡¦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
8 research outputs found
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
Author
A Agresti
Atsushi Ohtsu
+32Â more
C Tournigand
CG Moertel
CJ Allegra
CJ Allegra
CL Loprinzi
D Sargent
Dai Manaka
E Mamounas
Junichi Hasegawa
Junichi Sakamoto
Katsunori Shinozaki
Keiji Inoue
Kiyoshi Ishigure
Koichi Goto
Koji Oba
LEE Po-Huang
Masahito Kotaka
N Nagata
Quasar Collaborative Group
S Gill
S Marsoni
S McKenzie
Shigetoyo Saji
T André
T André
T André
T Kono
T Watanabe
Takanori Matsui
Takayuki Yoshino
Tetsuo Touyama
Toshiaki Watanabe
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
Author
A Gramont de
DJ Jonker
+37Â more
E Cutsem Van
E Cutsem Van
Eiji Oki
FF Kabbinavar
Hideo Baba
Hiroshi Saeki
HS Hochster
J Bennouna
J Cassidy
J Cassidy
J Sastre
J Tol
Kazuo Shirouzu
L Vamvakas
LB Saltz
LB Saltz
M Ducreux
M Nishino
Masami Kimura
MF Kozloff
Mototsugu Shimokawa
MT Seymour
Noriaki Sadanaga
PM Hoff
RM Goldberg
S Venderbosch
T Doi
Takaho Tanaka
Tetsuo Touyama
Tetsuya Kusumoto
V Heinemann
Y Uchima
Y Yamada
Yasunori Emi
Yoshihiko Maehara
Yoshito Akagi
Yutaka Ogata
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
Phase II study alternating mFOLFOX 6 and FOLFIRI (FIREFOX) plus bevacizumab (bev) regimen in first-line treatment of advanced colorectal cancer in Japanese patients (KSCC 0801).
Author
Eiji Oki
Hideo Baba
+11Â more
Hironori Samura
Hiroshi Saeki
Kazuo Shirouzu
Shoji Natsugoe
Shoji Tokunaga
Tetsuo Touyama
Yasunori Emi
Yoshihiko Maehara
Yoshihiro Kakeji
Yoshito Akagi
Yutaka Ogata
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A prospective study of XELOXÂ plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC0902).
Author
Atsushi Kaibara
Eiji Oki
+13Â more
Hideo Baba
Hiroo Matsushita
Hiroshi Saeki
Kazuo Shirouzu
Masaaki Takeuchi
Mototugu Shimokawa
Noriaki Sadanaga
Takaho Tanaka
Tetsuo Touyama
Tetsuya Kusumoto
Yasunori Emi
Yoshihiko Maehara
Yutaka Ogata
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Tolerability study of adjuvant modified FOLFOX6 treatment in curatively resected stage II/III colon cancer (JFMC41-1001-C2: JOIN trial).
Author
Akinori Takagane
Atsushi Ohtsu
+18Â more
Dai Manaka
Hideyuki Ishida
Hiroshi Ishikawa
Junichi Hasegawa
Junichi Sakamoto
Katsunori Shinozaki
Kiyoshi Ishigure
Koichi Goto
Koji Oba
Masahito Kotaka
Shigetoyo Saji
Takanori Matsui
Takayuki Yoshino
Tetsuo Touyama
Toshiaki Watanabe
Yasushi Tsuji
Yoshinori Munemoto
Yutaka Ogata
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Author
A Kono
C Tournigand
+25Â more
CS Fuchs
F Innocenti
Fumihiro Taniguchi
H Minami
JM Hoskins
JY Douillard
K Araki
K Sai
LP Rivory
MC Haaz
Mitsuaki Manabe
N Yamamoto
Nobuyuki Mizunuma
S Hazama
T Satoh
T Shiozawa
Takaya Kusumi
Tetsuo Touyama
Y Ando
Y Kawato
Y Okuyama
Y Saito
Yoshinori Miyata
Yoshitaka Morita
ZY Hu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Author
Akihito Tsuji
Akiyoshi Kanazawa
+31Â more
Beutler
Eiji Oki
Falcone
Falvella
Goro Nakayama
Hideaki Bando
Hideki Sakisaka
Hiroya Taniguchi
Hoskins
Japan Society Clinical Oncology
Japanese Society for Cancer of the Colon and Rectum
Kaniwa
Kei Muro
Kentaro Yamazaki
Klastersky
Loupakis
Masahito Kotaka
Masato Nakamura
Masi
National Comprehensive Cancer Network
Onoue
Shigeyoshi Iwamoto
Takayuki Yoshino
Takeharu Yamanaka
Takeshi Kato
Tatsuro Yamaguchi
Tetsuo Touyama
Van Cutsem
Yamazaki
Yasunori Emi
Yoshinori Kagawa
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis
Author
A Ikehata
A Iwashita
+73Â more
A Iwashita
B Sartor
CC Tsai
Chikao Ando
D Siao
F Guo
F Takamoto
G Nishimura
H Hozumi
H Nishiura
H Okamoto
H Watari
HG Jung
HH Wang
HY Kang
I Hirata
JH Song
JM Choi
K Arakawa
K Hiramatsu
K Okada
Kazuhiko Nagasaka
Kenichi Komatsu
KM Chang
Koji Asano
KY Kwok
L Tzogias
LC Chen
M Aburada
M Kusanagi
M Miyagoshi
M Miyazaki
M Yamamoto
Machiko Kaizuka
Mai Murase
Masaaki Yamada
Masafumi Murai
Mika Sano
MT Chen
N Koyama
N Mantani
N Oshitani
Norihide Taniuchi
PY Lin
R Touyama
RR Scheline
S Higaki
S Hirasaki
S Shimizu
S Yoshinaga
Sunao Takeuchi
T Akao
T Hidaka
T Kitamura
T Mikami
T Yamano
T Yao
Takayuki Murase
Tetsuo Watanabe
The Examination Committee for Criteria of Metabolic Syndrome
TJ Ho
Toshinori Yazaki
V Markos
X Wu
Y Arimura
Y Ding
Y Kawata
Y Kimura
Y Nagata
Y Saito
Y Seino
YT Jan
Yutaka Nagata
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref